Botulism in horses is a rapidly progressive and often fatal form of paralysis caused by toxins produced by the bacterium Clostridium botulinum. The toxin blocks the nerve signals that tell muscles to contract, leading to a characteristic “flaccid” paralysis where muscles go limp rather than seizing up. Horses are among the most sensitive domestic animals to this toxin, and without treatment, case fatality rates can reach 90%.
How the Toxin Causes Paralysis
Clostridium botulinum spores live naturally in soil. Under the right conditions, particularly in low-oxygen, moist environments, the bacteria multiply and produce a potent neurotoxin. Once absorbed into a horse’s bloodstream, the toxin travels to the junctions where nerves meet muscles and blocks the release of the chemical messenger that triggers muscle contraction. Without that signal, muscles progressively lose their ability to function.
The result is a symmetrical weakness that typically spreads from the head and tail toward the rest of the body. Horses remain mentally alert throughout. They can still see and hear normally, but their muscles simply stop responding. In severe cases, the paralysis reaches the muscles that control breathing and the heart, which is how botulism kills.
Three Ways Horses Get Botulism
Horses can develop botulism through three distinct routes, each with a different mechanism.
Forage poisoning is the most common form in adult horses. It happens when a horse eats feed that already contains preformed toxin. Spoiled hay, particularly round bales that were baled at high moisture content, is a well-known source. Silage or haylage that wasn’t properly fermented (with a pH above 4.5) creates ideal conditions for toxin production. One of the most dangerous scenarios is when a small animal carcass, such as a bird or rodent, gets accidentally baled into hay during harvest. The decomposing body creates a perfect low-oxygen environment for the bacteria to grow and produce toxin.
Wound botulism occurs when Clostridium botulinum spores contaminate a deep wound and germinate in the low-oxygen tissue, producing toxin directly inside the horse’s body. This form is less common but can follow puncture wounds, surgical sites, or deep lacerations.
Toxicoinfectious botulism, known as “shaker foal syndrome,” affects foals under six months of age. Instead of ingesting preformed toxin, the foal swallows bacterial spores that then colonize the immature gastrointestinal tract and produce toxin from within. The highest incidence in the United States occurs in Kentucky and the mid-Atlantic region. Affected foals develop progressive muscle trembling, increasing episodes of recumbency, and difficulty swallowing.
Early Signs to Watch For
The earliest and most telling signs of botulism involve the tongue and tail. The tongue loses its normal tone and strength, so a horse may drool excessively or show slow, weak tongue retraction. Difficulty swallowing typically starts with solid food first. As the disease progresses, the horse may become unable to swallow liquids as well, eventually refusing food entirely.
Poor tail tone is another early finding. If you lift the tail and it drops limply without resistance, that’s a red flag. Other subtle early signs include:
- Slightly dilated pupils
- Drooping eyelids
- Decreased blink reflex
- General stiffness or exercise intolerance
- Muscle tremors
Weakness progresses over 12 hours to 10 days after toxin exposure, spreading to the entire body. Horses may develop a shuffling gait, stumble, or eventually become recumbent and unable to rise. Even at this stage, they typically stay alert and aware of their surroundings, which can be distressing for owners to witness.
Diagnosis Is Mostly Clinical
There is no rapid, definitive laboratory test for equine botulism. Veterinarians diagnose it primarily based on clinical signs and the process of ruling out other causes of weakness, such as equine protozoal myeloencephalitis or severe electrolyte imbalances. The tongue test, where a vet gently pulls the tongue out of the mouth and evaluates how quickly the horse retracts it, is one of the most useful bedside assessments. Slow or absent retraction strongly suggests botulism. Checking tail tone and eyelid reflexes adds further evidence.
Treatment and Survival Rates
The cornerstone of treatment is antitoxin, which binds circulating toxin before it can attach to more nerve endings. It cannot reverse damage already done, so early administration is critical. In a study of 92 adult horses treated at a veterinary hospital, the overall survival rate was 48%. But the difference antitoxin made was dramatic: roughly 59% of horses that received antitoxin survived, compared to only 10% of those that did not.
Beyond antitoxin, treatment is supportive. Horses that can’t swallow need to be fed through a tube to maintain nutrition and hydration. Those that become recumbent require intensive nursing care, including deep bedding, frequent repositioning to prevent pressure sores, and close monitoring of breathing. Recovery, when it happens, is slow because the body must grow new nerve endings to replace those the toxin destroyed. This process can take weeks.
The prognosis drops sharply once a horse can no longer stand. Most reports describe the outcome for recumbent horses as grave. In outbreak situations with limited veterinary intervention, fatality rates climb to 70% or higher depending on the toxin type involved.
Reducing the Risk
Feed management is the single most important preventive measure. Avoid feeding hay that was baled wet or rained on during harvest. Round bales carry higher risk than small square bales because moisture can become trapped in the center, creating pockets of anaerobic spoilage. Inspect hay for unusual odors, dark discoloration, or any sign of animal remains. Silage and haylage should only be fed if properly fermented to a pH of 4.5 or below; improperly fermented silage predictably causes botulism in horses.
Vaccination is available against one toxin type and is recommended by the American Association of Equine Practitioners for horses in endemic areas. Unvaccinated adult horses receive three initial doses at four-week intervals, then an annual booster. Pregnant mares that have been previously vaccinated get a single booster two to four weeks before foaling, which concentrates protective antibodies in the colostrum so the foal receives passive immunity. Mares that have never been vaccinated need the full three-dose series timed so the final dose falls two to four weeks before the expected foaling date.
For foals in high-risk regions like central Kentucky, maternal vaccination is the primary line of defense against shaker foal syndrome, since foals are too young to mount their own vaccine response during the vulnerable period.